IL1B and ulcer disease: They discovered that inhibiting gastric acid sufficiently with omeprazole prevented both ulcer recurrence and responses, indicating that acid may enhance gastric mucosal inflammation in response to IL-1β stimulation, resulting in gastric ulcers.